The electronic health record (EHR) has been touted as a tool that has the power to improve the quality of patient care, reduce costs, and improve overall efficiency in healthcare. At this year's American College of Cardiology 62nd Annual Scientific Session and Expo, information was presented from a study challenging that long-held belief.
The electronic health record (EHR) has been touted as a tool that has the power to improve the quality of patient care; reduce costs; and improve overall efficiency in healthcare. At this year’s American College of Cardiology 62nd Annual Scientific Session and Expo, Hormoz Kianfar, Harmony Leighton, Azriel Avezbadalov, Kunal Buch, and Todd Kerwin of New York Hospital Medical Center of Queens in Flushing, NY, presented information from a study they conducted which focused on the effect EHRs have on duplicate testing.
The EHR has been promoted as the silver bullet to many problems in healthcare for the past decade. In 2005, the RAND Corporation released a report in which they estimated that widespread implementation of EHRs could save the healthcare system more than $80 billion. In 2009, the HITECH Act was enacted to “promote the adoption and meaningful use of health information technology.” (Despite the efforts of the HITECH Act, the fact is that there is still an ongoing discussion as to what constitutes “meaningful use,” and the mere mention of this term to any provider is sure to make them cringe.) More specifically, the implementation of an EHR has been predicted to reduce the ordering of duplicate testing and, in fact, early data performed under highly controlled circumstances somewhat validated this hypothesis. However, the research team sought to test this theory in a real-world setting, and specifically examined the effect of the institution of an EHR on the ordering of duplicate transthoracic echocardiography in a hospital-based laboratory.
In short, the research team evaluated all echocardiograms performed during a 12-month period (July 2007-June 2008) prior to the implementation of an EHR at a 500-bed, urban teaching hospital, and then assessed whether an echocardiogram was repeated within 6 to 12 months of the index study. These results were then compared to the 12-month period after implementation of an EHR. Not only did the team not observe a decrease in the rate of duplicate testing following the implementation of an EHR, but they observed a significant increase. Although the research group admits that there were some limitations in their analysis (did not assess appropriateness, confounders, change in procedural volume over time, etc), they nonetheless feel that their data combined with other recent studies should “promote a more rigorous assessment of the initial claims of the benefits associated with EHR implementation.”
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More